ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
85 hedge funds and large institutions have $123M invested in Antares Pharma, Inc. in 2014 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 27 increasing their positions, 31 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
92% less call options, than puts
Call options by funds: $41K | Put options by funds: $498K
Holders
85
Holding in Top 10
–
Calls
$41K
Puts
$498K
Top Buyers
| 1 | +$4.86M | |
| 2 | +$2.2M | |
| 3 | +$2M | |
| 4 |
ACM
Ashford Capital Management
Wilmington,
Delaware
|
+$609K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$315K |
Top Sellers
| 1 | -$11.2M | |
| 2 | -$3.83M | |
| 3 | -$3.41M | |
| 4 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$1.75M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$875K |